Diversity and inclusion in the legal profession: disclosure of cancer and other health conditions by lawyers with disabilities and lawyers who identify as LGBTQ + .


Journal

Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557

Informations de publication

Date de publication:
02 2022
Historique:
received: 08 11 2021
accepted: 15 11 2021
pubmed: 3 2 2022
medline: 3 3 2022
entrez: 2 2 2022
Statut: ppublish

Résumé

Given the training and experience of lawyers, we assumed that a study of lawyers' willingness to disclose disability in the workplace would provide an example of the actions of a group knowledgeable about disability law. The current study accounts for the effect of visibility of disability, onset and type of disability, and whether the lawyer has made an accommodation request. We also investigate the role of other individual characteristics, such as sexual orientation, gender identity, race/ethnicity, age, and job-related characteristics, in willingness to disclose. We use data from the first phase of a longitudinal national survey of lawyers in the USA to estimate the odds of disclosing disability to co-workers, management, and clients using proportional odds models. Lawyers with less visible disabilities, those with mental health disabilities, and those who work for smaller organizations have lower odds of disclosing to co-workers, management, and clients as compared to their counterparts. Attorneys who have requested accommodations are more willing to disclose as compared to those who have not, but only to co-workers and management. Women are less likely than men to disclose to management and clients. However, gender is not a significant determinant of disclosure to co-workers. Older attorneys are more likely to disclose to clients, whereas attorneys with children are less likely to disclose to co-workers. Lastly, lower perceived prejudice and the presence of co-workers with disabilities are associated with higher disclosure scores, but not for all groups. Individuals who acquired a disability at a relatively early point in life and those with more visible disabilities are more likely to disclose. However, such willingness is affected by the intersection of disability with other individual and firm-level characteristics. The findings imply that those with less visible disabilities and with health conditions acquired later in life are less likely to disclose. The relevance of the findings is heightened by the altered work conditions and demands imposed by the COVID-19 pandemic for cancer survivors.

Identifiants

pubmed: 35107800
doi: 10.1007/s11764-021-01143-2
pii: 10.1007/s11764-021-01143-2
pmc: PMC8809243
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-182

Subventions

Organisme : Southeast ADA Center
ID : 90DPAD0005-01-00
Organisme : National Institute on Disability, Independent Living, and Rehabilitation Research
ID : 90RTEM0006-01-00
Organisme : Increasing Supported Decision Making in Community Living
ID : 90DP0076-01-00
Organisme : Southeast ADA Center
ID : 90DP0090-01-00
Organisme : ADA-PARC, Lex Frieden PI
ID : H133A12000
Organisme : RRTC on Employer Practices Leading to Successful Employment Outcomes Among People with Disabilities, Douglas Kruse PI
ID : RTEM21000058

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Psychooncology. 2013 Jul;22(7):1639-44
pubmed: 22996725
J Cancer Surviv. 2022 Feb;16(1):152-164
pubmed: 35107798
Arthritis Care Res (Hoboken). 2015 May;67(6):855-64
pubmed: 25370701
J Occup Rehabil. 2020 Dec;30(4):521-536
pubmed: 33156435
J Homosex. 2019;66(8):1148-1177
pubmed: 30052497
Arthritis Care Res (Hoboken). 2022 Oct;74(10):1751-1760
pubmed: 33973368
J Interpers Violence. 2009 May;24(5):819-43
pubmed: 18463311
Arthritis Rheum. 2009 Dec 15;61(12):1753-61
pubmed: 19950308
Disabil Rehabil. 2019 Aug;41(16):1914-1924
pubmed: 29558221
Disabil Health J. 2021 Oct;14(4):101161
pubmed: 34246591
J Appl Psychol. 2016 Mar;101(3):430-49
pubmed: 26595753
J Occup Rehabil. 2020 Mar;30(1):84-92
pubmed: 31410722
J Occup Rehabil. 2021 Mar;31(1):153-165
pubmed: 32410153
Ind Labor Relat Rev. 2015 Aug;68(4):916-954
pubmed: 26778848
J Occup Rehabil. 2012 Jun;22(2):155-65
pubmed: 22020624
J Cancer Surviv. 2022 Feb;16(1):200-212
pubmed: 35107794
J Cancer Surviv. 2022 Feb;16(1):183-199
pubmed: 35107797
J Occup Rehabil. 2011 Dec;21(4):526-36
pubmed: 21400039
J Occup Rehabil. 2020 Dec;30(4):511-520
pubmed: 33146784
J Cancer Surviv. 2020 Oct;14(5):614-623
pubmed: 32785876
Deviant Behav. 2019;40(8):942-956
pubmed: 31885409
J Occup Rehabil. 2020 Mar;30(1):115-124
pubmed: 31359226
J Adolesc Young Adult Oncol. 2020 Aug;9(4):528-533
pubmed: 32255699
J Psychosoc Oncol. 2021;39(2):252-267
pubmed: 33355039
J Occup Rehabil. 2020 Dec;30(4):537-564
pubmed: 33219465
J Cancer Surviv. 2016 Apr;10(2):416-24
pubmed: 26407809
J Occup Rehabil. 2020 Dec;30(4):689-690
pubmed: 33258057
Disabil Rehabil. 2018 Dec;40(25):2971-2986
pubmed: 28797182
Psychiatr Rehabil J. 2011 Fall;35(2):145-7
pubmed: 22020846
Occup Med (Lond). 2010 Dec;60(8):611-7
pubmed: 20855546
Am J Law Med. 2021 Mar;47(1):9-61
pubmed: 34247678
J Occup Rehabil. 2017 Dec;27(4):507-519
pubmed: 29181808
J Occup Rehabil. 2007 Mar;17(1):83-92
pubmed: 17318459
BMC Psychiatry. 2012 Feb 16;12:11
pubmed: 22339944
Psychooncology. 2000 Jul-Aug;9(4):273-82
pubmed: 10960925
Eur J Cancer Care (Engl). 2017 Sep;26(5):
pubmed: 28809461
J Occup Rehabil. 2019 Mar;29(1):140-149
pubmed: 29696476
Disabil Health J. 2021 Jul;14(3):101085
pubmed: 33744158
Mult Scler. 2014 Jun;20(7):871-6
pubmed: 24263383
Mult Scler. 2015 Feb;21(2):225-34
pubmed: 25070678
J Occup Rehabil. 2021 Sep;31(3):638-651
pubmed: 33523376
Disabil Rehabil. 2021 Mar;43(5):597-610
pubmed: 31282214
J Cancer Surviv. 2016 Dec;10(6):1035-1050
pubmed: 27170116
J Cancer Surviv. 2022 Feb;16(1):142-151
pubmed: 35107801

Auteurs

Fitore Hyseni (F)

Maxwell School of Citizenship and Public Affairs, Syracuse University, Syracuse, USA.

Arzana Myderrizi (A)

Rockefeller College of Public Affairs and Policy, State University of New York at Albany, Albany, USA.

Peter Blanck (P)

Burton Blatt Institute, Syracuse University, 950 Irving Avenue, Suite 446, Syracuse, NY, 13244, USA. pblanck@syr.edu.
Peter Blanck, University Professor & Chairman Burton Blatt Institute, Syracuse University, 950 Irving Avenue, Suite 446, Syracuse, NY, 13244, USA. pblanck@syr.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH